| Travatan | |
|---|---|
| Dosing | 1 drop qhs (qAM dosing is considered acceptable.) |
| Chem Specs | travoprost 0.004% |
| Quantities | 2.5, 5ml |
| Cost | 154.55 / 5ml (generic) 208.00 (Z formulation - see below) |
| Class | prostaglandin analog |
| Action | Believed to increase uveoscleral aqueous outflow. |
| Usage | Indicated for lowering IOP with open-angle glaucoma or ocular hypertension for those who are intolerant of other IOP lowering medications or insufficiently responsive to another IOP lowering medication. 28% - 30% IOP reduction. |
| Side Effects | Pigmentation of the iris, eyelid and eyelashes, and growth of eyelashes. Possible cystoid macular edema in pseudophakes and/or aphakes. Possible reactivation of herpes keratitis. Possible corneal thinning. 30 to 50% report ocular hyperemea. 3% discontinue use for this reason. May exacerbate uveitis. |
| Contraindications | Hypersensitivity to travoprost or any other ingredients in the product. |
| Pediatric use | Below the age of 16 years not recommended due to "potential safety concerns related to increased pigmentation following long-term chronic use". |
| Pregnancy | Category C. Embryo-fetal lethality shown in rats with low dose subcutaneous injections. |
| Travatan Z uses "sofzia" preservative rather than BAK. |